๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Heterogeneity of the lymphokine-activated killer cell phenotype

โœ Scribed by Brian S. Chadwick; Richard G. Miller


Book ID
113134679
Publisher
Elsevier Science
Year
1991
Tongue
English
Weight
632 KB
Volume
132
Category
Article
ISSN
0008-8749

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Lymphokine-activated killer cell activit
โœ Dwain L. Thiele; Peter E. Lipsky ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› Elsevier Science ๐ŸŒ English โš– 147 KB
Technical aspects of lymphokine-activate
โœ C. S. Carter; S. F. Leitman; H. Cullis; L. M. Muul; K. Nason-Burchenal; S. A. Ro ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 655 KB

Adoptive immunotherapy is a novel approach to treating patients with cancer, utilizing as therapy a patient's own peripheral blood lymphocytes that have been activated by incubation with interleukin-2 (IL-2). These cells develop the ability to mediate tumor regression in vivo and are referred to as

Phenotypic and functional analysis of ly
โœ Anita S. -F. Chong; Alexandre Aleksijevic; Philip Scuderi; Evan M. Hersh; Willia ๐Ÿ“‚ Article ๐Ÿ“… 1989 ๐Ÿ› Springer-Verlag ๐ŸŒ English โš– 945 KB

Lymphokine-activated killer (LAK) cells are generated by the culture of peripheral blood lymphocytes with interleukin-2 (IL-2). A variety of cells, including T-lymphocytes and natural killer (NK) cells, can be activated by IL-2 to exhibit the ability to kill multiple tumor and "modified-self" target

Apheresis techniques in lymphokine-activ
โœ Irena Sniecinski; Kim Sentinella; Kim Margolin; Bonnie Mills ๐Ÿ“‚ Article ๐Ÿ“… 1988 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 385 KB

Adoptive transfer of autologous lymphokine-activated killer cells (LAK) in conjunction with recombinant interleukin-2 (rIL-2) has been reported to produce significant regression in metastatic disease in patients with advanced cancer. In an effort to confirm the results reported by the Surgery Branch